Growth Metrics

Bio-Techne (TECH) Total Debt Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 103.99%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -39.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -39.39%
Dec 31, 2025 -13.33%
Sep 30, 2025 0.00%
Jun 30, 2025 8.46%
Mar 31, 2025 -15.17%
Dec 31, 2024 -32.89%
Sep 30, 2024 -32.09%
Jun 30, 2024 -9.76%
Mar 31, 2024 3.66%
Dec 31, 2023 123.50%
Sep 30, 2023 62.37%
Jun 30, 2023 38.13%
Mar 31, 2023 44.88%
Dec 31, 2022 -26.37%
Sep 30, 2022 -7.06%
Jun 30, 2022 -25.02%
Mar 31, 2022 24.53%
Dec 31, 2021 21.25%
Sep 30, 2021 -7.64%
Jun 30, 2021 -4.32%
Mar 31, 2021 -49.70%
Dec 31, 2020 -41.50%
Sep 30, 2020 -34.80%
Jun 30, 2020 -29.38%
Mar 31, 2020 -20.83%
Dec 31, 2019 -29.78%
Sep 30, 2019 -13.43%
Jun 30, 2019 49.01%
Mar 31, 2019 31.89%
Dec 31, 2018 31.16%
Sep 30, 2018 48.38%
Jun 30, 2018 -17.09%
Mar 31, 2018 -3.63%
Dec 31, 2017 2.12%
Sep 30, 2017 -3.81%
Jun 30, 2017 346.85%
Mar 31, 2017 160.39%
Dec 31, 2016 150.11%
Sep 30, 2016 139.34%
Jun 30, 2016 25.34%
Mar 31, 2016 1,869.89%
Dec 31, 2015 13.05%
Sep 30, 2015 46.76%
Jun 30, 2015 943.30%